Glenmark Pharmaceuticals announced that Hocine Sidi, Director of the company has resigned from the Board with effect from November 25, 2014.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,027 INR | +0.77% | +1.60% | +20.32% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.32% | 3.53B | |
+21.62% | 44.12B | |
+22.22% | 22.61B | |
+19.11% | 15.11B | |
+14.31% | 13.61B | |
+62.00% | 13.34B | |
-8.98% | 6.94B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+15.65% | 5.75B |
- Stock Market
- Equities
- GLENMARK Stock
- News Glenmark Pharmaceuticals Limited
- Glenmark Pharmaceuticals Announces Resignation of Hocine Sidi as Director